Ever Source Wealth Advisors, LLC Centessa Pharmaceuticals PLC Transaction History
Ever Source Wealth Advisors, LLC
- $1.95 Billion
- Q2 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 20 shares of CNTA stock, worth $455. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20Holding current value
$455% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CNTA
# of Institutions
127Shares Held
122MCall Options Held
638KPut Options Held
146K-
Medicxi Ventures Management (Jersey) LTD20MShares$455 Million73.31% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$227 Million100.0% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$221 Million4.43% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.4MShares$192 Million0.2% of portfolio
-
Janus Henderson Group PLC London, X06.53MShares$149 Million0.04% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $2.15B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...